News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Gideon Blumenthal, MD

Gideon Blumenthal, MD

Gideon Blumenthal, MD, is vice president of Clinical Development Oncology at Merck

Articles by Gideon Blumenthal, MD

D. Ross Camidge, MD, PhD; Gideon Blumenthal, MD, vice president, Clinical Development Oncology, Merck

How An Interest in Translational Research and Drug Development Helps Evolve Regulatory Practices: With D. Ross Camidge, MD, PhD; and Gideon Blumenthal, MD

ByRoss Camidge, MD, PhD,Gideon Blumenthal, MD

November 26th 2025

Drs Camidge and Blumenthal discussed Dr Blumenthal's experience serving on both sides of the oncology regulatory divide.

Latest Updated Articles

Trending on OncLive

FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer

Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM

FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC

NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer

Real-World SEER Data Highlight Age-Related Survival Gap in ICI-Treated Advanced RCC